TABLE 3.
Susceptibility and resistance to TB medicines according to WHO criteria (n = 20)a
| Group | Medicine | No. of patients |
|
|---|---|---|---|
| Resistant | Susceptible | ||
| Fluoroquinolones | Ofloxacin | 8 | 12 |
| Levofloxacin (Minsk vs RIVM)b | 2/3 | 18/17 | |
| Injectable anti-TB medication | Amikacin | 5 | 15 |
| Capreomycin | 5 | 15 | |
| Kanamycin | 7 | 13 | |
| Streptomycin | 20 | 0 | |
| Other core second-line agents | Etionamide | 1 | 19 |
| Protionamide | 1 | 19 | |
| Cycloserine | 1 | 19 | |
| Add-on agents | Pyrazinamide | 5 | 15 |
| Ethambutol | 16 | 4 | |
a
See reference 31.
b
RIVM, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.